Andrew J. Fromkin

Andrew J. Fromkin has an estimated net worth of $3.93 Million. This is based on reported shares across multiple companies, which include Radius Health, Inc., Immunovant, Inc., Regado Biosciences Inc, and CLINICAL DATA INC.

2007 was Andrew J. Fromkin's most active year for acquiring shares with 12 total transactions. Andrew J. Fromkin's most active month to acquire stocks was the month of November. 2011 was Andrew J. Fromkin's most active year for disposing of shares, totalling 10 transactions. Andrew J. Fromkin's most active month to dispose stocks was the month of March. 2013 saw Andrew J. Fromkin paying a total of $8,373,608.85 for 2,427,133 shares, this is the most they've acquired in one year. In 2011 Andrew J. Fromkin cashed out on 1,089,133 shares for a total of $17,829,500.84, their largest year based on trade value.